Published in Biotech Law Weekly, November 17th, 2006
"Fiscal 2006 was a year that was marked by numerous accomplishments for Enzo and reflected the continued investments in our life sciences business, therapeutic development programs and clinical laboratory," said Barry Weiner, president. "These investments, which impacted the results, have already yielded tangible benefits. Among others, benefits are reflected in our expanded intellectual property coverage in...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Biotech Law Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.